Hydrazide-hydrazones of 3-methoxybenzoic acid and 4-tert-butylbenzoic acid with promising antibacterial activity against Bacillus spp

References

• Moellering RC. Jr Discovering new antimicrobial agents. Int J Antimicrob Agents 2011;37:2–9
   PubMed Web of Science ®Google Scholar
• Coates A, Hu Y, Bax R, Page C. The future challenges facing the development of new antimicrobial drugs. Nat Rev Drug Discov 2002;1:895–910
   PubMed Web of Science ®Google Scholar
• Rollas S, Küçükgüzel ŞG. Biological activities of hydrazone derivatives. Molecules 2007;12:1910–39
   PubMed Web of Science ®Google Scholar
• Narang R, Narasimhan B, Sharma S. A review on biological activities and chemical synthesis of hydrazide derivatives. Curr Med Chem 2012;19:569–612
   PubMed Web of Science ®Google Scholar
• Ansari MF, Siddiqui SM, Agarwal SM, et al Metronidazole hydrazone conjugates: design, synthesis, antiamoebic and molecular docking studies. Bioorg Med Chem Lett 2015;25:3545–9
   PubMed Web of Science ®Google Scholar
• Şenkardeş S, Kaushik-Basu N, Drumaz İ, et al Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors. Eur J Med Chem 2016;108:301–8
   PubMed Web of Science ®Google Scholar
• Inam A, Siddiqui SM, Macedo TS, et al. Design, synthesis and biological evaluation of 3-[4-(7-chloro-quinolin-4-yl)-piperazin-1-yl]-propionic acid hydrazones as antiprotozoal agents. Eur J Med Chem 2014;75:67–76
   PubMed Web of Science ®Google Scholar
• Moldovan CM, Oniga O, Pârvu OO, et al Synthesis and anti-inflammatoryevaluation of some new acyl-hydrazonesbearing 2-aryl-thiazole Eur J Med Chem 2011;46:526–34
   PubMed Web of Science ®Google Scholar
• Machakanur SS, Patil BR, Badiger DS, et al Synthesis, characterization and anticancer evaluation of novel tri-arm star shaped 1,3,5-triazine hydrazones. J Mol Struct 2012;1011:121–7
   Web of Science ®Google Scholar
• Nasr T, Bondock S, Youns M. Anticancer activity of new coumarin substituted hydrazide-hydrazone derivatives. Eur J Med Chem 2014;76:539–48
   PubMed Web of Science ®Google Scholar
• Koçyiğit-Kaymakçıoğlu B, Oruç-Emre EE, Unsalan S, Rollas S. Antituberculosis activity of hydrazones derived from 4-fluorobenzoic acid hydrazide. Med Chem Res 2009;18:277–86
   Web of Science ®Google Scholar
• Morjan RY, Mkadmh AM, Beadham I, et al Antibacterial activities of novel nicotinic acid hydrazides and their conversion into N-acetyl-1,3,4-oxadiazoles. Bioorg Med Chem Lett 2014;24:5796–800
   PubMed Web of Science ®Google Scholar
• Backers GL, Neumann DM, Jursic BS. Synthesis and antifungal activity of substituted salicylaldehyde hydrazones, hydrazides and sulfohydrazides. Bioorg Med Chem 2014;22:4629–36
   PubMed Web of Science ®Google Scholar
• Kumar D, Kapoor A, Thangadurai A, et al Synthesis, antimicrobial and QSAR studies of 3-ethoxy-4-hydroxybenzylidene/4-nitrobenzylidene hydrazides. Chin Chem Lett 2011;22:1293–6
   Web of Science ®Google Scholar
• Kodisundaram P, Amirthaganesan S, Balasankar T. Antimicrobial evaluation of a set of heterobicyclic methylthiadiazole hydrazones: synthesis, characterization, and SAR studies. J Agric Food Chem 2013;61:11952–6
   PubMed Web of Science ®Google Scholar
• Özkay Y, Tunalı Y, Karaca H, Işıkdağ İ. Antimicrobial activity and a SAR study of some novel benzimidazole derivatives bearing hydrazone moiety. Eur J Med Chem 2010;45:3292–8
   Web of Science ®Google Scholar
• McCalla DR, Reuvers A, Kaiser C. Mode of action of nitrofurazone. J Bacteriol 1970;104:1126–34
   PubMed Web of Science ®Google Scholar
• Chatterjee SN, Ghosh S. Mechanism of action of furazolidone: inter-strand cross-linking in DNA & liquid holding recovery of Vibrio cholerae cells. Indian J Biochem Biophys 1979;16:125–30
   PubMed Web of Science ®Google Scholar
• Ali BH. Some pharmacological and toxicological properties of furazolidone. Vet Res Commun 1983;6:1–11
   PubMed Web of Science ®Google Scholar
• Popiołek Ł, Biernasiuk A, Malm A. Design, synthesis, and in vitro antimicrobial activity of new furan/thiophene-1,3-benzothiazin-4-one hybrids. J Het Chem 2016;53:479–86
   Web of Science ®Google Scholar
• Popiołek Ł, Biernasiuk A, Malm A. Synthesis and in vitro antimicrobial activity of nalidixic acid hydrazones. J Het Chem 2016. [Epub ahead of print]. doi:10.1002/jhet.2468
   PubMedGoogle Scholar
• Popiołek Ł, Kosikowska U, Wujec M, Malm A. Synthesis and antimicrobial evaluation of new Schiff base hydrazones bearing 1,2,4-triazole moiety. Phosphorus Sulfur 2014;189:1611–23
   Web of Science ®Google Scholar
• HyperChem™ Professional 2009, Release 8.0.8 for Windows, Hypercube, Inc., 1115 NW 4th Street, Gainesville, Florida 32601, USA
   Google Scholar
• Kümmerle AE, Schmitt M, Cardozo SVS, et al Design, synthesis, and pharmacological evaluation of N-acylhydrazones and novel conformationally constrained compounds as selective and potent orally active phosphodiesterase-4 inhibitors. J Med Chem 2012;55:7525–45
   PubMed Web of Science ®Google Scholar
• Murty MSR, Ram KR, Rao BR, et al Synthesis, characterization, and anticancer studies of S and N alkyl piperazine-substituted positional isomers of 1,2,4-triazole derivatives. Med Chem Res 2014;23:1661–71
   Web of Science ®Google Scholar
• European Committee for Antimicrobial Susceptibility Testing (EUCAST) determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. EUCAST discussion document E. Dis 5.1 Clin Microbiol Infect 2003;9:1–7
   Google Scholar
• Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts. M27-S4. 2012 Wayne, PA
   Google Scholar
• Popiołek Ł, Biernasiuk A, Malm A. Synthesis and antimicrobial activity of new 1,3-thiazolidin-4-one derivatives obtained from carboxylic acid hydrazides. Phosphorus Sulfur 2015;190:251–60
   Web of Science ®Google Scholar
• Wiegand I, Hilpert K, Hancock REW. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 2008;3:163–75
   PubMed Web of Science ®Google Scholar
• O'Donnell F, Smyth TJ, Ramachandran VN, Smyth WF. A study of the antimicrobial activity of selected synthetic and naturally occurring quinolines. Int J Antimicrob Agents 2010;35:30–8
   PubMed Web of Science ®Google Scholar
• Kotiranta A, Lounatmaa K, Haapasalo M. Epidemiology and pathogenesis of Bacillus cereus infections. Microbes Infect 2000;2:189–98
   PubMed Web of Science ®Google Scholar
• Bottone EJ. Bacillus cereus, a volatile human pathogen. Clin Microbiol Rev 2010;23:382–98
   PubMed Web of Science ®Google Scholar